Lightner Amy L, Fletcher Joel G, Pemberton John H, Mathis Kellie L, Raffals Laura E, Smyrk Thomas
1 Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota 2 Division of Radiology, Mayo Clinic, Rochester, Minnesota 3 Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota 4 Division of Pathology, Mayo Clinic, Rochester, Minnesota.
Dis Colon Rectum. 2017 Nov;60(11):1201-1208. doi: 10.1097/DCR.0000000000000918.
After IPAA, 8% of patients with ulcerative colitis are later diagnosed with Crohn's disease of the pouch, associated with an increased rate of pouch failure. No study has reported on how often the clinical diagnosis is correlated with histologic findings of Crohn's disease in the excised pouch.
The purpose of this study was to determine whether the clinical diagnosis is consistent with pathologic confirmation at pouch excision.
The study was conducted at a tertiary IBD referral center.
Patients with chronic ulcerative colitis who underwent pouch excision for presumed Crohn's disease of the pouch were included.
Preoperative evaluation and pathologic variables at the time of pouch excision were measured.
A total of 35 patients underwent pouch excision for Crohn's disease of the pouch based on a combination of clinical, radiographic, and endoscopic findings. Seven (20%) had surgical pathology consistent with Crohn's disease at pouch excision. There were no differences in those 7 patients and the remaining 28 in terms of diagnosis at colectomy, primary pouch symptoms, prepouch inflammation, ulceration, or granulomas at endoscopy. In the nonpathology-confirmed Crohn's disease, 40% (n = 11) had an anastomotic leak at time of IPAA versus 0% in the Crohn's disease group, and 86% (n = 24) had symptoms of pouch dysfunction within 5 months of ileostomy reversal versus 13 months in the Crohn's disease group. Of 28 without pathology-confirmed Crohn's disease, 100% (n = 28) were treated with antibiotics, 68% (n = 19) with steroids, 59% (n = 16) with immunomodulators, and 57% (n = 15) with biologic therapy for Crohn's disease of the pouch.
The study was limited by its single-center scope and lack of an established definition for Crohn's disease of the pouch.
Pathologic confirmation of Crohn's disease was given to only one fifth of patients who underwent pouch excision for Crohn's disease of the pouch. Given the histologic variability in Crohn's disease, it may be unreasonable to expect histologic confirmation in every case; still, the diagnosis of Crohn's disease of the pouch may be overly ascribed, resulting in unnecessary immunosuppressive medications and exclusion from consideration for pouch reconstructive surgery. See Video Abstract at http://links.lww.com/DCRA432.
回肠储袋肛管吻合术(IPAA)后,8%的溃疡性结肠炎患者随后被诊断为储袋克罗恩病,这与储袋功能衰竭发生率增加相关。尚无研究报道切除的储袋中克罗恩病的临床诊断与组织学表现的相符频率。
本研究的目的是确定储袋切除时的临床诊断与病理证实是否一致。
该研究在一家三级炎症性肠病转诊中心进行。
纳入因疑似储袋克罗恩病而接受储袋切除的慢性溃疡性结肠炎患者。
测量储袋切除时的术前评估和病理变量。
共有35例患者因储袋克罗恩病,根据临床、影像学和内镜检查结果接受了储袋切除。7例(20%)在储袋切除时手术病理与克罗恩病相符。这7例患者与其余28例患者在结肠切除术时的诊断、原发性储袋症状、储袋前炎症、溃疡或内镜下肉芽肿方面无差异。在未得到病理证实的克罗恩病患者中,40%(n = 11)在IPAA时发生吻合口漏,而克罗恩病组为0%;86%(n = 24)在回肠造口还纳术后5个月内出现储袋功能障碍症状,而克罗恩病组为13个月。在28例未得到病理证实的克罗恩病患者中,100%(n = 28)接受了抗生素治疗,68%(n = 19)接受了类固醇治疗,59%(n = 16)接受了免疫调节剂治疗,57%(n = 15)接受了针对储袋克罗恩病的生物治疗。
本研究受单中心范围限制,且缺乏储袋克罗恩病的确切定义。
因储袋克罗恩病接受储袋切除的患者中,仅五分之一得到了克罗恩病的病理证实。鉴于克罗恩病组织学表现的变异性,期望每例都得到组织学证实可能不合理;尽管如此,储袋克罗恩病的诊断可能被过度归因,导致不必要的免疫抑制药物治疗,并被排除在储袋重建手术的考虑范围之外。见视频摘要:http://links.lww.com/DCRA432 。